Region
Featured experience
Pony AI $413 million IPO
We advised Pony AI on its IPO, concurrent private placements and Nasdaq listing
Horizon Robotics HK$5.41 billion IPO
We advised Horizon Robotics on its IPO and HKEX listing
CK Hutchison Holdings $2 billion notes offering
We advised CK Hutchison Holdings on its Rule 144A / Regulation S notes offering
Hollysys Automation $1.66 billion acquisition by Ascendent Capital Partners
We are advising Hollysys on the acquisition
I-Mab $177 million follow-on secondary offering of ADSs
We advised the underwriters on the equity offering
JOINN Laboratories HK$6.5 billion IPO
We advised JOINN Laboratories on its IPO and HKEX listing.
Victory for PwC China in putative class action
We secured a complete dismissal for PwC China in a lawsuit by Gridsum Holding shareholders
Fantasia $150 million high-yield notes reopening and concurrent tender offer
We advised the initial purchasers on the offering and the dealer managers on the tender offer for Fantasia’s senior notes
InnoCare Pharma HK$3.04 billion share placement
We advised InnoCare Pharma in the placement of new shares
New Horizon Health HK$2.04 billion IPO
We advised New Horizon Health on its IPO and HKEX listing
Akeso HK$1.19 billion share placement
We advised the placing agent in the placement of new shares
UP Fintech $65 million convertible notes private placement
We are advising UP Fintech, a Nasdaq-listed online brokerage firm, on its private placement of convertible notes
Youdao $238 million equity follow-on offering
We advised Youdao on its offering of ADSs
Adagene $161 million IPO
We advised Adagene on its IPO and Nasdaq listing